|
|
 |
Chair
Claudine Isaacs, MDCM, FRCP(C)
Associate Professor of Medicine
Director, Clinical Breast Cancer Program
Co-Director, Fisher Center for Familial Cancer Research
Georgetown University Medical Center
Washington, District of Columbia
Minetta C. Liu, MD
Associate Professor of Medicine
Lombardi Comprehensive Cancer Center
Georgetown University Medical Center
Washington, District of Columbia
Faculty
Jennifer Eng Wong, MD, MPH
Assistant Professor of Medical Oncology
Lombardi Comprehensive Cancer Center
Georgetown University Medical Center
Washington, District of Columbia
Jennifer Eng-Wong, MD, MPH is assistant professor of medical oncology at the Lombardi Comprehensive Cancer Center at Georgetown University in Washington, District of Columbia. Dr Eng-Wong earned her medical degree from SUNY-Stony Brook Medical School in Stony Brook, New York and her master of public health from George Washington University in Washington, District of Columbia. She completed a residency in internal medicine at the University of California Davis Medical Center in Davis, California, and a combined fellowship in medical oncology and cancer prevention at the National Cancer Institute in Bethesda, Maryland.
Dr Eng-Wong’s research interests include breast cancer prevention using targeted prevention agents and lifestyle factors. She serves as a member of the Georgetown University Hospital’s Clinical Research Committee and General Clinical Research Center Advisory Committee. Dr Eng-Wong is a member of the American Society of Clinical Oncology and the American Association for Cancer Research and has published several peer-reviewed manuscripts, review articles, and abstracts.
William J. Gradishar, MD
Professor of Medicine
Northwestern University
Feinberg School of Medicine
Chicago, Illinois
William J. Gradishar, MD is a professor of medicine in the Division of Hematology and Medical Oncology, Department of Medicine, at the Feinberg School of Medicine at Northwestern University in Chicago, Illinois, and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. He also serves as director of breast medical oncology, associate director of the Lynn Sage Comprehensive Breast Program, and program director of Northwestern University’s hematology/oncology fellowship training program. His research focuses on the development of novel therapeutics for the treatment of breast cancer.
A fellow of the American College of Physicians, Dr Gradishar is also a member of the American Association for Cancer Research, the American Federation for Clinical Research, and the Association of Subspecialty Professors. He has been active in the American Society of Clinical Oncology as the previous chair of the oncology training committee and cancer communication committee. He is a member of the breast cancer core committee of the Eastern Cooperative Oncology Group, the committee on cancer of the American College of Surgeons, the National Comprehensive Cancer Network (NCCN) breast cancer guidelines panel, and the NCCN breast cancer prevention panel. In addition, he serves as a consultant to the oncology drug advisory committee of the FDA. He is the editor-in-chief of Journal Watch Oncology-Hematology. He is on the editorial boards of the Journal of Clinical Oncology, Clinical Cancer Research, Clinical Breast Cancer, Breast Disease: A Year Book Quarterly, Journal of Oncology, and the European Journal of Clinical and Medical Oncology. He has published in the area of breast cancer therapeutics, with a focus on new therapeutic strategies and breast cancer management.
Dr Gradishar received his MD from the University of Illinois Abraham School of Medicine in Chicago. He completed a residency and chief residency in internal medicine at Michael Reese Hospital and Medical Center in Chicago and a fellowship in medical oncology at the University of Chicago.
Claudine Isaacs, MDCM, FRCP(C)
Associate Professor of Medicine
Director, Clinical Breast Cancer Program
Co-Director, Fisher Center for Familial Cancer Research
Georgetown University Medical Center
Washington, District of Columbia
Claudine Isaacs, MDCM, FRCP(C) is an associate professor of medicine and oncology and director of the Clinical Breast Cancer Program at Georgetown University Medical Center in Washington, DC. She is board certified in internal medicine and the subspecialty of medical oncology.
Dr Isaacs earned her MDCM from McGill University in Montreal, Quebec, Canada. She completed an internal medicine residency, as well as a hematology and medical oncology residency/fellowship at McGill University. Further, she completed a fellowship in breast cancer at Georgetown University Medical Center.
Dr Isaacs is a member of the Royal College of Physicians and Surgeons of Canada (fellow) and the American Society of Clinical Oncology (Cancer Education Committee). In addition, she is a member of the Steering Committee of the Cancer Genetics Network and the PLCO Trial. She serves as the principal investigator on many clinical trials in the prevention and treatment of breast cancer. Dr Isaacs also holds several university service and teaching positions.
Dr Isaacs is a recipient of many awards and honors. She is currently a principal investigator for several National Cancer Institute trials and serves as a co-investigator for several other trials. She has been extensively published in peer-reviewed journals, books, and abstracts and has been invited to make numerous presentations nationally.
V. Craig Jordan, OBE, PhD, DSc, FMedSci
Scientific Director, Lombardi Comprehensive Cancer Center
Vice Chair, Department of Oncology
Professor of Oncology and Pharmacology
Georgetown University Medical Center
Washington, District of Columbia
V. Craig Jordan, OBE, PhD, DSc, FMedSci is scientific director at the Lombardi Comprehensive Cancer Center, vice chair of the department of oncology, and professor of oncology and pharmacology at Georgetown University Medical Center in Washington, District of Columbia. Dr Jordan earned a bachelor of science, a doctorate of philosophy (pharmacology), and a doctor of science degree from the University of Leeds in the United Kingdom.
Dr Jordan’s research specialty is in investigating and developing drugs for breast cancer treatment and prevention. He is known as “the Father of Tamoxifen” and was the first to discover the breast cancer prevention properties of tamoxifen. His work has subsequently branched out into the prevention of osteoporosis and breast cancer with raloxifene.
A highly regarded researcher, Dr Jordan has received multiple awards for his work including the Kettering Prize, the American Cancer Society Medal of Honor, the American Society of Clinical Oncology 38th David A. Karnofsky Award and Lecture, Honorary Fellow Royal Society of Medicine, Fellow Academy of Medical Sciences, and he is an elected member of the National Academy of Sciences (USA). In 2002 Dr Jordan was made an officer of the Order of the British Empire (OBE) for his services to international breast cancer research. He has published more than 500 abstracts, along with a total of more than 600 books, refereed papers, chapters, and reviews.
Minetta C. Liu, MD
Associate Professor of Medicine
Lombardi Comprehensive Cancer Center
Georgetown University Medical Center
Washington, District of Columbia
Minetta C. Liu, MD is the director of Translational Breast Cancer Research and the Biomarker Section Chief of the Clinical Molecular Diagnostics Laboratory at Georgetown University’s Lombardi Comprehensive Cancer Center in Washington, DC. An associate professor of medicine and oncology, her primary research focus is on the efficient development of reliable predictors of treatment response. Her clinical goals are to provide multidisciplinary breast cancer care and offer appropriate patients access to novel therapeutic agents and diagnostic tools. Toward that end, she serves as the principal investigator for several institutional, cooperative groups, and industry-sponsored clinical trials in breast cancer.
Dr Liu received her medical degree from Jefferson Medical College in Philadelphia, Pennsylvania before completing a residency in internal medicine and a fellowship in hematology/oncology at Georgetown University Medical Center. Dr Liu is a diplomate of the American Board of Internal Medicine with certification in internal medicine and medical oncology. She serves on the Breast Committee, Solid Tumor Correlative Sciences Committee, and Executive Committee for the Cancer and Leukemia Group B. Her clinical and translational research efforts are currently supported by grants from such sponsors as the National Cancer Institute and the Department of Defense.
Scott Spear, MD
Professor and Chairman
Department of Plastic Surgery
Georgetown University Hospital
Washington, District of Columbia
Scott L. Spear, MD is professor and chairman of the department of plastic surgery at Georgetown University Hospital in Washington, District of Columbia. Dr Spear graduated from the University of Michigan with honors, and continued his education at the University of Chicago where he earned his medical degree. He spent his post-graduate years in a general surgery residency program at Harvard Medical School, and then entered a plastic surgery residency at the University of Miami.
Dr Spear has been a visiting professor at over a dozen prestigious universities, including Harvard, Yale, Stanford, Vanderbilt, the University of Pennsylvania, University of Chicago, University of Texas, University of Florida, Ohio State University, University of California, and the University of Toronto.
Dr Spear is a past president of the American Society of Plastic Surgeons and the Northeastern Society of Plastic and Reconstructive Surgeons. In addition, he is the founder and president of the Royal and Ancient Society of American Plastic Surgeons, and recently served on the board of directors for the Plastic Surgery Educational Foundation, the American Society of Plastic Surgeons, and the American Society for Aesthetic Plastic Surgery.
Dr Spear has published extensively on various aspects of plastic surgery and has testified as an expert regarding breast implants in front of Congress and the Food and Drug Administration. He has published over 229 papers and chapters, given 103 presentations, participated in 547 invited lectures, panels, and courses, and authored the textbook Surgery of the Breast: Principles and Art. He is the breast section editor for the Journal of Plastic and Reconstructive Surgery and his opinions are featured in many media forms such as the New York Times, The Washington Post, National Public Radio, CNN, ABC, NBC, FOX, and CBS.
Vered Stearns, MD
Associate Professor of Oncology
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins School of Medicine
Baltimore, Maryland
Vered Stearns, MD is associate professor of oncology at the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine in Baltimore, Maryland. Dr Stearns completed a BS equivalent at the Sackler Faculty of Medicine, Tel-Aviv University in Israel. After relocating to the United States, she earned her medical degree at the University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School. Dr Stearns completed her internal medicine residency at Georgetown University Medical Center in Washington, District of Columbia, and subsequently completed a fellowship at Georgetown University and the Lombardi Cancer Center in medical oncology.
Dr Stearns' research interest is in translational breast cancer research, and her long-term goal is to improve upon current practices by individualizing therapies for breast cancer. While administering standard chemotherapy in the preoperative setting, she examines molecular markers and functional imaging that may assist in early determination of sensitivity or resistance to treatments. She has also spent considerable time focusing on improving the quality of life of women who have survived their breast cancer and suffer bothersome hot flashes seeking a better understanding of the mechanism of agents that control hot flashes.
Dr Stearns is a member of the Breast Cancer Research Foundation (BCRF) Scientific Advisory Committee and a member of the American Society of Clinical Oncology and the American Association for Cancer Research. She is the author of more than 50 editorials, abstracts, and articles and has authored or
coauthored 7 book chapters. She is an associate editor for Advanced Studies in Oncology, and on the editorial advisory board for Oncology. In March 2004 the Society of Surgical Oncology awarded the most cited article published in Annals of Surgical Oncology in 2002 to Dr Stearns et al for: “Sentinel lymphadenectomy following neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer.”
|
|
|